Pappas Life Science Ventures Iii L.p. A.m. is 10% at CoLucid Pharmaceuticals, Inc. (CLCD). They have made 1 open-market trade across 1 company since 2015, most recently 2015-05-11.
CIK 0001573854
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $3.0M since 2015, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLCD | 116,317 | $5.4M |
Shares reported on the most recent Form 4, priced at the 2015-05-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLCD | BUY | 2015-05-11 | 2015-05-12 | $10.00 | $3.0M | -18.6% | +1.2% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.